Merck’s Stock Plummets 10%: HPV Vaccine Woes and Disappointing Guidance Shake Investors
Merck's stock dropped by 10% due to disappointing forecasts and declining sales. Adjusted EPS for 2025 projected between $8.88 and $9.03, below the expected $9.13. Revenue forecast of $64.1 billion…